Commercial determinants of health: future directions

S Friel, J Collin, M Daube, A Depoux, N Freudenberg… - The Lancet, 2023 - thelancet.com
This paper is about the future role of the commercial sector in global health and health
equity. The discussion is not about the overthrow of capitalism nor a full-throated embrace of …

Western diets and chronic diseases

TE Adolph, H Tilg - Nature medicine, 2024 - nature.com
Abstract 'Westernization', which incorporates industrial, cultural and dietary trends, has
paralleled the rise of noncommunicable diseases across the globe. Today, the Western-style …

Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021

SE Vollset, HS Ababneh, YH Abate, C Abbafati… - The Lancet, 2024 - thelancet.com
Background Future trends in disease burden and drivers of health are of great interest to
policy makers and the public at large. This information can be used for policy and long-term …

Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of …

M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate… - The Lancet, 2024 - thelancet.com
Background Understanding the health consequences associated with exposure to risk
factors is necessary to inform public health policy and practice. To systematically quantify the …

Ultra-processed foods and cardiometabolic health: public health policies to reduce consumption cannot wait

M Touvier, ML da Costa Louzada, D Mozaffarian… - bmj, 2023 - bmj.com
Ultra-processed foods and cardiometabolic health: public health policies to reduce consumption
cannot wait Page 1 the bmj | BMJ 2023;383:e075294 | doi: 10.1136/bmj-2023-075294 1 Food …

Food is medicine: a presidential advisory from the American Heart Association

KG Volpp, SA Berkowitz, SV Sharma, CAM Anderson… - Circulation, 2023 - ahajournals.org
Unhealthy diets are a major impediment to achieving a healthier population in the United
States. Although there is a relatively clear sense of what constitutes a healthy diet, most of …

Opportunities and challenges following approval of resmetirom for MASH liver disease

JV Lazarus, D Ivancovsky Wajcman, HE Mark… - Nature Medicine, 2024 - nature.com
Opportunities and challenges following approval of resmetirom for MASH liver disease | Nature
Medicine Skip to main content Thank you for visiting nature.com. You are using a browser …

Conceptualising commercial entities in public health: beyond unhealthy commodities and transnational corporations

J Lacy-Nichols, S Nandi, M Mialon, J McCambridge… - The Lancet, 2023 - thelancet.com
Most public health research on the commercial determinants of health (CDOH) to date has
focused on a narrow segment of commercial actors. These actors are generally the …